![](/img/cover-not-exists.png)
P-521 Phase II trial evaluating combination, weekly gemcitabineand docetaxel in progressive, chemotherapy-exposed NSCLC: Preliminary results of OPN 003
Langer, C., Huang, C., Millenson, M., Sherman, E., Seldomridge, J., Schol, J., Rogatko, A., Treat, J.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)81014-1
Date:
July, 2005
File:
PDF, 145 KB
english, 2005